In early October, the Advertising Club of New York sponsored a luncheon titled "Rx for Drug Marketers: Tackling DTC." Representatives
from pharma companies, agencies, media, and government participated in a panel discussion, with each member offering their
"take" on DTC marketing. Panel members, pictured here from left to right, are Cliff Thumma, director, market analytics, Pfizer;
Mark Morris, chairman, Bates North America; Bob Ziltz, national ad director, Prevention magazine; Sibyl Shalo, senior editor,
Pharmaceutical Executive; Kathryn Aikin, PhD, social science analyst, division of drug, marketing, advertising, and communications,
FDA; Deborah Dick-Rath, executive director, global advertising, Novartis Pharmaceuticals; Joanne Davis, president, joanne
davis consulting and Advertising Club board member.